Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001719755-18-000003
Filing Date
2018-02-14
Accepted
2018-02-13 20:10:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G a2018schedule13g-spero.htm SC 13G 123296
  Complete submission text file 0001719755-18-000003.txt   124889
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Subject) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90168 | Film No.: 18606459
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043
Business Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043 650-335-5278
GV 2015, L.P. (Filed by) CIK: 0001719755 (see all company filings)

EIN.: 472144612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G